Cargando…
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
BACKGROUND: Cachexia is a multi-factorial, systemic syndrome that especially affects patients with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival and quality of life. The most important clinical feature of cachexia is the excessive wasting of skeletal muscle...
Autores principales: | Mueller, Tara C., Bachmann, Jeannine, Prokopchuk, Olga, Friess, Helmut, Martignoni, Marc E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746781/ https://www.ncbi.nlm.nih.gov/pubmed/26856534 http://dx.doi.org/10.1186/s12885-016-2121-8 |
Ejemplares similares
-
Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
por: Bachmann, Jeannine, et al.
Publicado: (2009) -
The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
por: Schwarz, S., et al.
Publicado: (2017) -
A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
por: Prokopchuk, Olga, et al.
Publicado: (2021) -
Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003) -
Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition – a cross-sectional observational study
por: Mueller, Tara Catharina, et al.
Publicado: (2020)